Methods of treatment with myosin modulator
Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in c...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZHANG, David DEL RIO, Carlos L CARLSON, Timothy LAMPL, Kathy L MCDOWELL, Robert KANE, Brian Edmund FANG, Liang HENZE, Marcus Patrick LAMBING, Joseph LI, Wanying SEMIGRAN, Marc J AUBELE, Danielle L DESAI, Milind Y FERNANDES, Sarah NISSEN, Steve MEALIFFE, Matthew Edwards EDELBERG, Jay M SEHL, Louis Charles MA, Grace Yanfei SEHNERT, Amy |
| description | Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020378197A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020378197A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020378197A13</originalsourceid><addsrcrecordid>eNrjZNDyTS3JyE8pVshPUygpSk0syU3NK1EozyzJUMitzC_OzFPIzU8pzUksyS_iYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBkYGxuYWhpbmjobGxKkCAPS4Kj4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods of treatment with myosin modulator</title><source>esp@cenet</source><creator>ZHANG, David ; DEL RIO, Carlos L ; CARLSON, Timothy ; LAMPL, Kathy L ; MCDOWELL, Robert ; KANE, Brian Edmund ; FANG, Liang ; HENZE, Marcus Patrick ; LAMBING, Joseph ; LI, Wanying ; SEMIGRAN, Marc J ; AUBELE, Danielle L ; DESAI, Milind Y ; FERNANDES, Sarah ; NISSEN, Steve ; MEALIFFE, Matthew Edwards ; EDELBERG, Jay M ; SEHL, Louis Charles ; MA, Grace Yanfei ; SEHNERT, Amy</creator><creatorcontrib>ZHANG, David ; DEL RIO, Carlos L ; CARLSON, Timothy ; LAMPL, Kathy L ; MCDOWELL, Robert ; KANE, Brian Edmund ; FANG, Liang ; HENZE, Marcus Patrick ; LAMBING, Joseph ; LI, Wanying ; SEMIGRAN, Marc J ; AUBELE, Danielle L ; DESAI, Milind Y ; FERNANDES, Sarah ; NISSEN, Steve ; MEALIFFE, Matthew Edwards ; EDELBERG, Jay M ; SEHL, Louis Charles ; MA, Grace Yanfei ; SEHNERT, Amy</creatorcontrib><description>Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220526&DB=EPODOC&CC=AU&NR=2020378197A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220526&DB=EPODOC&CC=AU&NR=2020378197A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHANG, David</creatorcontrib><creatorcontrib>DEL RIO, Carlos L</creatorcontrib><creatorcontrib>CARLSON, Timothy</creatorcontrib><creatorcontrib>LAMPL, Kathy L</creatorcontrib><creatorcontrib>MCDOWELL, Robert</creatorcontrib><creatorcontrib>KANE, Brian Edmund</creatorcontrib><creatorcontrib>FANG, Liang</creatorcontrib><creatorcontrib>HENZE, Marcus Patrick</creatorcontrib><creatorcontrib>LAMBING, Joseph</creatorcontrib><creatorcontrib>LI, Wanying</creatorcontrib><creatorcontrib>SEMIGRAN, Marc J</creatorcontrib><creatorcontrib>AUBELE, Danielle L</creatorcontrib><creatorcontrib>DESAI, Milind Y</creatorcontrib><creatorcontrib>FERNANDES, Sarah</creatorcontrib><creatorcontrib>NISSEN, Steve</creatorcontrib><creatorcontrib>MEALIFFE, Matthew Edwards</creatorcontrib><creatorcontrib>EDELBERG, Jay M</creatorcontrib><creatorcontrib>SEHL, Louis Charles</creatorcontrib><creatorcontrib>MA, Grace Yanfei</creatorcontrib><creatorcontrib>SEHNERT, Amy</creatorcontrib><title>Methods of treatment with myosin modulator</title><description>Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDyTS3JyE8pVshPUygpSk0syU3NK1EozyzJUMitzC_OzFPIzU8pzUksyS_iYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBkYGxuYWhpbmjobGxKkCAPS4Kj4</recordid><startdate>20220526</startdate><enddate>20220526</enddate><creator>ZHANG, David</creator><creator>DEL RIO, Carlos L</creator><creator>CARLSON, Timothy</creator><creator>LAMPL, Kathy L</creator><creator>MCDOWELL, Robert</creator><creator>KANE, Brian Edmund</creator><creator>FANG, Liang</creator><creator>HENZE, Marcus Patrick</creator><creator>LAMBING, Joseph</creator><creator>LI, Wanying</creator><creator>SEMIGRAN, Marc J</creator><creator>AUBELE, Danielle L</creator><creator>DESAI, Milind Y</creator><creator>FERNANDES, Sarah</creator><creator>NISSEN, Steve</creator><creator>MEALIFFE, Matthew Edwards</creator><creator>EDELBERG, Jay M</creator><creator>SEHL, Louis Charles</creator><creator>MA, Grace Yanfei</creator><creator>SEHNERT, Amy</creator><scope>EVB</scope></search><sort><creationdate>20220526</creationdate><title>Methods of treatment with myosin modulator</title><author>ZHANG, David ; DEL RIO, Carlos L ; CARLSON, Timothy ; LAMPL, Kathy L ; MCDOWELL, Robert ; KANE, Brian Edmund ; FANG, Liang ; HENZE, Marcus Patrick ; LAMBING, Joseph ; LI, Wanying ; SEMIGRAN, Marc J ; AUBELE, Danielle L ; DESAI, Milind Y ; FERNANDES, Sarah ; NISSEN, Steve ; MEALIFFE, Matthew Edwards ; EDELBERG, Jay M ; SEHL, Louis Charles ; MA, Grace Yanfei ; SEHNERT, Amy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020378197A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHANG, David</creatorcontrib><creatorcontrib>DEL RIO, Carlos L</creatorcontrib><creatorcontrib>CARLSON, Timothy</creatorcontrib><creatorcontrib>LAMPL, Kathy L</creatorcontrib><creatorcontrib>MCDOWELL, Robert</creatorcontrib><creatorcontrib>KANE, Brian Edmund</creatorcontrib><creatorcontrib>FANG, Liang</creatorcontrib><creatorcontrib>HENZE, Marcus Patrick</creatorcontrib><creatorcontrib>LAMBING, Joseph</creatorcontrib><creatorcontrib>LI, Wanying</creatorcontrib><creatorcontrib>SEMIGRAN, Marc J</creatorcontrib><creatorcontrib>AUBELE, Danielle L</creatorcontrib><creatorcontrib>DESAI, Milind Y</creatorcontrib><creatorcontrib>FERNANDES, Sarah</creatorcontrib><creatorcontrib>NISSEN, Steve</creatorcontrib><creatorcontrib>MEALIFFE, Matthew Edwards</creatorcontrib><creatorcontrib>EDELBERG, Jay M</creatorcontrib><creatorcontrib>SEHL, Louis Charles</creatorcontrib><creatorcontrib>MA, Grace Yanfei</creatorcontrib><creatorcontrib>SEHNERT, Amy</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHANG, David</au><au>DEL RIO, Carlos L</au><au>CARLSON, Timothy</au><au>LAMPL, Kathy L</au><au>MCDOWELL, Robert</au><au>KANE, Brian Edmund</au><au>FANG, Liang</au><au>HENZE, Marcus Patrick</au><au>LAMBING, Joseph</au><au>LI, Wanying</au><au>SEMIGRAN, Marc J</au><au>AUBELE, Danielle L</au><au>DESAI, Milind Y</au><au>FERNANDES, Sarah</au><au>NISSEN, Steve</au><au>MEALIFFE, Matthew Edwards</au><au>EDELBERG, Jay M</au><au>SEHL, Louis Charles</au><au>MA, Grace Yanfei</au><au>SEHNERT, Amy</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods of treatment with myosin modulator</title><date>2022-05-26</date><risdate>2022</risdate><abstract>Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2020378197A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Methods of treatment with myosin modulator |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHANG,%20David&rft.date=2022-05-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020378197A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |